Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrinogen concentrate in high-risk cardiac surgery
NCT01623531Phase 3Completed
- Sponsor
- Nova Scotia Health
- Start
- Feb 2014
- Primary completion
- Mar 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Fibrinogen human in perioperative bleeding, sponsored by Nova Scotia Health. Started Feb 2014; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
perioperative bleeding
Beyond the preview
Go deeper on NCT01623531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01623531.